+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 55Years
All Genders
Healthy Volunteers
ID07257965

Study to Find the Minimum Number of Infective Mosquito Bites Needed to Cause Malaria Infection in Healthy Thai Adults Using Controlled Plasmodium Vivax Mosquito Challenge

Led by University of Oxford · Updated on 2026-03-27

24

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the minimum number of mosquito bites infected with Plasmodium vivax needed to reliably cause malaria infection in healthy adults from Thailand. This study aims to develop a mosquito-delivered controlled human malaria infection CHMI model that better reflects natural transmission, supports safer vaccine testing, and improves relevance to endemic populations. The study is funded by the UK Wellcome Trust and builds on previous human challenge studies with P. vivax and P. falciparum. Participants will be exposed to bites from 1 to 3 P. vivax-infected mosquitoes in a sequential adaptive design to find the lowest infective dose. The study begins with one mosquito bite and increases to two or three if infection is not consistently achieved. This approach avoids excessive parasite exposure that could affect vaccine efficacy assessments. The research takes place at the Faculty of Tropical Medicine in Thailand, an expert center for malaria research. Volunteers will be closely monitored in a hospital setting until antimalarial treatment is completed and symptoms improve. Follow-up includes clinical assessments, immune response testing up to one year after treatment, and monitoring for any adverse events. The primary outcome is the minimum number of infected mosquito bites needed to cause infection within 21 days. Participants must remain reachable and reside locally during the study and follow-up period, which lasts about one year after treatment initiation.

CONDITIONS

Brief Title

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

Research Team

N

Nicholas Day, MD

J

Jetsumon Sattabongkot Prachumsri, Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here